FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of Complete Genomics, the Mountain View, Calif-based sequencing services firm said in a document filed with the US Securities and Exchange Commission on Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.